GlassScriptPhysician profile
Matthew Hefner
NPI 1750700050
$639.00
in general payments reported to CMS, 2019-2025
11 companies · $56.44 in 2025
The $56.44 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $195 · 2023: $185 · 2024: $203 · 2025: $56.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $141.49 | 2022 | |
| Abbott Laboratories | $133.44 | 2023-2025 | Proclaim, Eterna |
| Providence Medical Technology, INC. | $103.49 | 2024 | |
| Boston Scientific Corporation | $81.87 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Alexion Pharmaceuticals, INC. | $30.81 | 2022 | |
| Medtronic, INC. | $30.77 | 2024 | Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $27.57 | 2023 | Andexxa |
| Tempus Ai, INC | $24.63 | 2024 | Xt Cdx |
| Innovation Technologies INC | $24.34 | 2024 | Irrisept |
| Smith+Nephew, INC. | $20.63 | 2025 | Pico |
| Stryker Corporation | $19.96 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hefner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.